1. Executive Summary |
2. Global Synthetic Biology Market Introduction |
2.1. Global Synthetic Biology Market – Taxonomy |
2.2. Global Synthetic Biology Market –Definitions |
2.2.1. Product Type |
2.2.2. Technology |
2.2.3. Application |
2.2.4. Region |
3. Global Synthetic Biology Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Current Trends |
3.5. Global Synthetic Biology Market Dynamic Factors – Impact Analysis |
3.6. Mergers, Acquisitions, and Collaborations |
4. Global Synthetic Biology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Synthetic Biology Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1. Core Products |
5.1.1. Synthetic DNA |
5.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Synthetic Genes |
5.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.1.3. Synthetic Cells |
5.1.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3.3. Market Opportunity Analysis |
5.1.4. Chassis organisms |
5.1.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.4.3. Market Opportunity Analysis |
5.1.5. XNO (Xeno Nucleic Acid) |
5.1.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.5.3. Market Opportunity Analysis |
5.2. Core Products |
5.2.1. DNA Synthesis |
5.2.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3. Market Opportunity Analysis |
5.2.2. Oligonucleotide Synthesis |
5.2.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
6. Global Synthetic Biology Market, By Technology, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1. Bioinformatics |
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Microfluidics |
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Genetic Engineering |
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. DNA Sequencing |
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Nucleotide Synthesis and Sequencing |
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Integrated Systems |
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
7. Global Synthetic Biology Market, By Application, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1. Pharmaceuticals & Diagnostics |
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Chemicals |
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Biofuels |
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Bioplastics |
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Synthetic Biology Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1. North America |
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific |
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. MEA |
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Synthetic Biology Market – Opportunity Analysis Index, By Product Type, Technology, Application, and Country, 2022 – 2028 |
9. North America Synthetic Biology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Core Products |
9.1.1.1. Synthetic DNA |
9.1.1.2. Synthetic Genes |
9.1.1.3. Synthetic Cells |
9.1.1.4. Chassis organisms |
9.1.1.5. XNO (Xeno Nucleic Acid) |
9.1.2. Enabling Products |
9.1.2.1. DNA Synthesis |
9.1.2.2. Oligonucleotide Synthesis |
9.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Bioinformatics |
9.2.2. Microfluidics |
9.2.3. Genetic Engineering |
9.2.4. DNA Sequencing |
9.2.5. Nucleotide Synthesis and Sequencing |
9.2.6. Integrated Systems |
9.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Pharmaceuticals & Diagnostics |
9.3.2. Chemicals |
9.3.3. Biofuels |
9.3.4. Bioplastics |
9.3.5. Others |
9.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.4.1. United States |
9.4.2. Canada |
9.5. North America Synthetic Biology Market – Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
9.6. North America Synthetic Biology Market Dynamics – Trends |
10. Europe Synthetic Biology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Core Products |
10.1.1.1. Synthetic DNA |
10.1.1.2. Synthetic Genes |
10.1.1.3. Synthetic Cells |
10.1.1.4. Chassis organisms |
10.1.1.5. XNO (Xeno Nucleic Acid) |
10.1.2. Enabling Products |
10.1.2.1. DNA Synthesis |
10.1.2.2. Oligonucleotide Synthesis |
10.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Bioinformatics |
10.2.2. Microfluidics |
10.2.3. Genetic Engineering |
10.2.4. DNA Sequencing |
10.2.5. Nucleotide Synthesis and Sequencing |
10.2.6. Integrated Systems |
10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Pharmaceuticals & Diagnostics |
10.3.2. Chemicals |
10.3.3. Biofuels |
10.3.4. Bioplastics |
10.3.5. Others |
10.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.4.1. UK |
10.4.2. Germany |
10.4.3. France |
10.4.4. Italy |
10.4.5. Spain |
10.4.6. Rest of Europe |
10.5. Europe Synthetic Biology Market – Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
10.6. Europe Synthetic Biology Market Dynamics – Trends |
11. Asia Pacific Synthetic Biology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
11.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Core Products |
11.1.1.1. Synthetic DNA |
11.1.1.2. Synthetic Genes |
11.1.1.3. Synthetic Cells |
11.1.1.4. Chassis organisms |
11.1.1.5. XNO (Xeno Nucleic Acid) |
11.1.2. Enabling Products |
11.1.2.1. DNA Synthesis |
11.1.2.2. Oligonucleotide Synthesis |
11.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Bioinformatics |
11.2.2. Microfluidics |
11.2.3. Genetic Engineering |
11.2.4. DNA Sequencing |
11.2.5. Nucleotide Synthesis and Sequencing |
11.2.6. Integrated Systems |
11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Pharmaceuticals & Diagnostics |
11.3.2. Chemicals |
11.3.3. Biofuels |
11.3.4. Bioplastics |
11.3.5. Others |
11.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.4.1. China |
11.4.2. India |
11.4.3. ANZ |
11.4.4. Japan |
11.4.5. Rest of APAC |
11.5. Asia Pacific Synthetic Biology Market – Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
11.6. Asia Pacific Synthetic Biology Market Dynamics – Trends |
12. MEA Synthetic Biology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
12.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Core Products |
12.1.1.1. Synthetic DNA |
12.1.1.2. Synthetic Genes |
12.1.1.3. Synthetic Cells |
12.1.1.4. Chassis organisms |
12.1.1.5. XNO (Xeno Nucleic Acid) |
12.1.2. Enabling Products |
12.1.2.1. DNA Synthesis |
12.1.2.2. Oligonucleotide Synthesis |
12.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Bioinformatics |
12.2.2. Microfluidics |
12.2.3. Genetic Engineering |
12.2.4. DNA Sequencing |
12.2.5. Nucleotide Synthesis and Sequencing |
12.2.6. Integrated Systems |
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Pharmaceuticals & Diagnostics |
12.3.2. Chemicals |
12.3.3. Biofuels |
12.3.4. Bioplastics |
12.3.5. Others |
12.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.4.1. GCC Countries |
12.4.2. South Africa |
12.4.3. Rest of MEA |
12.5. MEA Synthetic Biology Market – Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
12.6. MEA Synthetic Biology Market Dynamics – Trends |
13. Latin America Synthetic Biology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
13.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Core Products |
13.1.1.1. Synthetic DNA |
13.1.1.2. Synthetic Genes |
13.1.1.3. Synthetic Cells |
13.1.1.4. Chassis organisms |
13.1.1.5. XNO (Xeno Nucleic Acid) |
13.1.2. Enabling Products |
13.1.2.1. DNA Synthesis |
13.1.2.2. Oligonucleotide Synthesis |
13.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Bioinformatics |
13.2.2. Microfluidics |
13.2.3. Genetic Engineering |
13.2.4. DNA Sequencing |
13.2.5. Nucleotide Synthesis and Sequencing |
13.2.6. Integrated Systems |
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.3.1. Pharmaceuticals & Diagnostics |
13.3.2. Chemicals |
13.3.3. Biofuels |
13.3.4. Bioplastics |
13.3.5. Others |
13.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.4.1. Brazil |
13.4.2. Mexico |
13.4.3. Argentina |
13.4.4. Rest of LA |
13.5. Latin America Synthetic Biology Market – Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
13.6. Latin America Synthetic Biology Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Thermo Fisher Scientific, Inc. |
14.2.2. Genscript |
14.2.3. ProteoGenix |
14.2.4. OriGene Technologies Inc. |
14.2.5. Integrated DNA technologies |
14.2.6. Eurofins Scientific, Inc. |
14.2.7. Pareto Biotechnologies |
14.2.8. Amyris Inc. |
14.2.9. TeselaGen |
14.2.10. Synthetic Genomics Inc. |
15. Research Methodology |
16. Key Assumptions and Acronyms |